Let Today's Technology Help You Develop
Tomorrow's Drugs
The Benefits of Using Scientific Computing in Drug Development
Why is it that at the same time lead discovery is flourishing with the help of a fully-sequenced human genome and new drug discovery technologies, the pharmaceutical industry is experiencing an alarming slowdown in new drug applications and drying product pipelines?
The heart of the problem, according to the FDA whitepaper Innovation/ Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products , is the failure in the industry to employ new technologies (such as computer-based predictive models) in the drug development process.
Listen to this recorded webinar to learn how the joint Accelrys and HP scientific computing solution can help speed up the drug development process, as proven by success stories in organizations such as AstraZeneca, Bristol-Myers Squibb, Merck, Sanofi-Aventis, Taiho Pharmaceutical, Transform Pharmaceuticals, and more. Learn more about the technology that can help you:
accelerate formulation design and development
guide active pharmaceutical ingredient selection
screen for polymorphs and API/excipient chemical incompatibility
ensure processability and manufacturability
enhance batch-to-batch quality control
optimize scientific computing performance with specific HP cluster configurations
To request the recordings and slides from this webinar series, fill out the form below. The links will be sent to the e-mail address that you provide.